This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharmaceutical Compliance Congress (PCC) 2026
April 27-29, 2026
The Ritz-Carlton, Tysons Corner | McLean, VA
Book Now
Menu
Book
Key Sessions
Craig Bleifer
Prosecutor Panel: The Big Picture in Life Science Enforcement
McGuireWoods LLP
Tara McCarthy
Chief Compliance Officer Panel: Drivers for Change and Challenges for the Year Ahead
Dovetail Consulting Group
keyboard_arrow_right

2026 Day 1 Agenda - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
close
2026 Day 1 Agenda - ET (Eastern Time, GMT-05:00)
close
Experience Based Sessions: Tailored Content to Enhance Learning and Drive Opportunities to Build New Support Networks with Peers
Showing 1 of 1 Streams
2:15pm - 3:00pm
ADVANCED From Compliance Leader to Board Member: Elevating Your Strategic Impact
  • Understanding the different types of Board opportunities and positions and what is required for each
  • Overview of HHS-OIG’s expectations and recommendations for Board oversight of ethics and compliance
  • Essential competencies: critical skills and experiences that help compliance leaders transition to board service
  • Writing your Board resume: understanding elements will help you stand out
  • Building your board profile: developing the visibility, network, and credentials that open boardroom doors
  • Tools and tips for running a compliance committee that align with HHS-OIG Guidance
  • Mahnu Davar - Partner, Arnold & Porter
  • Sujata Dayal - Independent Board Director, Emergent BioSolutions
  • Felicia Heimer - Head of Rare Disease Compliance, Worldwide Compliance & Business Ethics, Amgen and Co-Author of OIG's Practical Guidance for Health Care Governing Boards on Compliance Oversight
COMMUNITY CONVERSATIONS: THOUGHT LEADERSHIP ALONGSIDE INTERACTIVE ROUNDTABLE SESSIONS: led by subject matter experts who will share the latest thinking, these sessions offer a unique opportunity to gain both cutting-edge insights alongside meaningful peer exchanges to share working practices and extend your network.
Showing 1 of 1 Streams
4:15pm - 5:00pm
R&D Compliance Risks Under the False Claims Act
  • Interpreting the latest EO and DOJ guidance impacting R&D
  • Examining HCP interactions under R&D
  • Examining risk exposure and approaches to designing policies to mitigate risk
  • Nikki Reeves - Partner, FDA & Life Sciences, King & Spalding
  • Roberta Rima - Vice President, Global Compliance Audit, Monitoring, Analytics, Zimmer Biomet
  • Natasha Trifun - Head of Enterprise Compliance & Risk, AstraZeneca
Next2026 Day 2 Agenda
Filter
Streams
Formats
Choose Day